Announcements and Notices - [Other - Business Update]

Akeso Inc. operates operatesa s a biotech company. The compnay develops treatments and therapies for various types of diseases. Akeso serves cutomers worldwide

Voluntary Announcement - The Inclusion In China'S National Reimbursement Drug List
Of Cadonilimab And Ivonescimab

Next Day Disclosure Return

Announcements and Notices - [Placing / Issue of Shares under a General Mandate]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Akeso Biopharma Inc (9926 HK)

Voluntary Announcement - The Inclusion In China'S National Reimbursement Drug List Of Cadonilimab And Ivonescimab

Next Day Disclosure Return

Completion Of Placing Of New Shares Under General Mandate

Placing Of New Shares Under General Mandate

Voluntary Announcement - Nmpa Approved The New Drug Application Of (Ebronucimab, Pcsk9)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)